Context Therapeutics Inc. · NASDAQ:CNTX

Soleus Capital Master Fund, L.P. reported a 7.60% stake in Context Therapeutics Inc. (Schedule 13G/A)

Event Mar 31, 2026 · Filed May 8, 2026

Soleus Capital Master Fund, L.P. reported a 7.60% stake in Context Therapeutics Inc., 6,963,141 shares, as a passive investor on Mar 31, 2026. Filed May 8, 2026 (Schedule 13G/A).

Stake
7.60%
Shares
6,963,141
Intent
Passive
What changed
Stake changed
Filed together
6 holders

The filing in full

HolderStakeShares
Soleus Capital Master Fund, L.P.7.60%6,963,141
Soleus Capital, LLC7.60%6,963,141
Soleus Capital Group, LLC7.60%6,963,141
Soleus Capital Management, L.P.7.60%6,963,141
Soleus GP, LLC7.60%6,963,141
Guy Levy7.60%6,963,141

Source

View original at SEC

Related